Balaxi Pharmaceuticals consolidated net profit rises 447.62% in the September 2026 quarter

Sales rise 44.84% to Rs 81.37 crore

Net profit of Balaxi Pharmaceuticals rose 447.62% to Rs 1.15 crore in the quarter ended September 2026 as against Rs 0.21 crore during the previous quarter ended September 2025. Sales rose 44.84% to Rs 81.37 crore in the quarter ended September 2026 as against Rs 56.18 crore during the previous quarter ended September 2025.

Particulars	Quarter Ended
	Sep. 2026	Sep. 2025	% Var.
Sales	81.37	56.18	45
OPM %	6.29	2.06	-
PBDT	3.44	1.86	85
PBT	2.02	1.38	46
NP	1.15	0.21	448

Powered by Capital Market - Live News